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ABSTRACT
Glucose transporter 1 (Glut1) is located in basolateral side 
of cells and mediates the unidirectional transport of glucose 
as non-insulin dependent glucose transporter protein. ıt is 
responsible for transportation of glucose especially to cancer 
cells and also transports arsenic compounds that is related 
with diabetes mellitus. The present study aimed to detect the 
allele and genotype frequencies of Glut1 -2841a>t single 
nucleotide polymorphism (SNP) in turkish population. 
Blood samples were collected from unrelated 100 male and 
110 female. Polymerase Chain reaction (PCr)-restriction 
Fragment length Polymorphism (rFlP) technique was used 
to analyze the blood samples. The distribution of -2841a>t 
SNP was 55.2%, 38.1% and 6.7% for aa, at and tt genotype, 
respectively. The frequency of the a allele was found as 74.3% 
and those of the t allele as 25.7%. The statistical evaluation 
represented that the allele frequencies was accordant with 
Hardy- Weinberg equilibrium (χ2 =0.002, p=0.97). This was 
the first study examining the frequencies of Glut1 -2841a>t 
polymorphism in turkish population. ın our opinion, these 
results can be used in epidemiological studies both in turkey 
and other countries. 
Keywords: Glucose transporter 1; turkish population; 
polymorphism; HpyCH4V.
INTRODUCTION
Glucose transporter 1 (Glut1), encoded by SLC2A gene, 
contains 12 alpha- helical transmembrane domain and is 
located in basolateral side of cells. depending on the glucose 
concentration, GLUT1 mediates the unidirectional transport 
of glucose from exo- to endofacial site in the cell (1).  GLUT1 
was firstly isolated from erythrocytes and the first isolated 
sugar transporter (1). The level of the GLUT1 is different in 
all cell types due to the glucose metabolism (1, 2). GLUT1 
mostly is expressed in the cardiovascular system, brain (in 
astrocytes), erythrocytes and less extent in the liver, the 
muscle, the kidney (tubular and glomerular areas) and the 
adipose tissue (1, 3).
The expression of GLUT1 is induced in the carcinogenesis 
and in the pathogenesis of diabetic nephropathy. Cancer cells 
need a greater energy for abnormal proliferation that causes 
metastasis. This energy is supplied by anaerobic glycolysis 
and 2 molecules of atP are obtained from a molecule of 
glucose. Thus, glucose uptake is extremely increased in 
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hypoxic cells.  a hypoxia responsive transcription factor 
(hypoxia-inducible factor 1 α (HıF-1 α) also serves as a 
regulator for proliferation and survival of cancer cells in 
this hypoxic condition. The HıF-1 α binds to the hypoxia 
responsive recognition element (Hre) and enhances the 
transcription of target genes including GLUT1 (2, 4-7). ın 
the pathogenesis of diabetic nephropathy in patients with 
diabetes mellitus, GLUT1 is one of the rate-limiting factors 
(8-10). a to t substitution is at – 2841 in the promoter 
region of GLUT1 gene so it can alter the over- or less-
expression of protein synthesis (8). ıncrease of blood glucose 
level causes hyperglycemia, which induces some changes in 
kidney such as increase of glomerular mesangial synthesis, 
renal hypertrophy, glomerulosclerosis and accumulation 
of extracellular matrix proteins. Furthermore, GLUT1 
transports arsenic compounds right along with glucose in 
erythrocytes, blood-brain barrier, epithelial cells, tubular 
and glomerular part of the kidney, and, thus, it may be an 
important protein in the risk of diabetes in case of chronic 
arsenic exposure (11, 12).
ıt is an indisputable fact that cancer is a disease of our age. 
according to the ıarC GloBoCaN 2012 data, 14.1 million 
individuals have cancer and 8.2 million people die due to the 
cancer every year in the world (13).  When we look at the 
turkey, approximately 103.070 men and 71.233 women have 
cancer in every year (14). ın 2014, 4.9 billion deaths occurred 
because of the diabetes and about 387 million individual had 
diabetes in the worldwide. Besides, the number of patients 
with diabetes is approximately 7.2 million and due to the 
diabetes 59000 people die every year in turkey (15).
Considering all of these incidences, the occurrence of 
cancer and diabetes may evaluate as a big threat for human 
nowadays. GLUT1 has been thought an important role in 
pathogenesis of cancer and diabetes. Thus, the aim of the 
study was to determine the genotype and allele frequency 
of -2841A>T single nucleotide polymorphism (SNP) in 
GLUT1 gene (rs710218; Geneıd: 6513; accession Number: 
Nm_006516) in turkish population and to compare our data 
with other populations.
MATERIAL AND METHODS
Subjects
The specimens were obtained from volunteers who were 
checked up in hospital. each subject provided written 
informed consent and approval (approval no: 06-242-13 in 
2013) for the use of human subjects was obtained from the 
institutional ethics committee. a small survey used to gather 
demographic information was given to all subjects. The 210 
blood samples were collected from turkish 100 male and 110 
female who is between the ages of 18 and 41 years. Whole 
blood samples were collected into ethylenediaminetetraacetic 
acid anticoagulant tubes and were kept at 4 °C until analyze. 
The anamneses indicate that individuals are unrelated and 
healthy (no history of disease such as chronic diseases and 
cancer). The study was in accordance with the principles of 
the declaration of Helsinki. 
Isolation of DNA and Genotyping of GLUT1 -2841A>T 
Polymorphism
dNa was extracted from whole-blood by Qiagen Qıaamp 
dNa mini Kit. dNa concentration was determined using 
the PicoGreen dsdNa quantitation kit (molecular Probes, 
eugene, or) according to the method recommended by the 
manufacturer.
For detection of the GLUT1 -2841A>T polymorphism, 
337 bp fragment was amplified by Polymerase Chain 
reaction (PCr) using the following primers: forward: 
5’-GCTGAGAATGGCCTTCCCTCAAT-3’ and reverse primer 
5’-CTGCCTTACTCAGCCCATGGGTC-3’. The PCr reaction 
mixture contained 10x PCr buffer, 200 μm dNtP, 10 μl from 
each of the primers, 1.25 u of Hot Star taq dNa polymerase 
(Qiagen), ~200 ng dNa and last volume completed with 
distilled water to 50 μl. amplification was conducted on a 
techne tc 512 PCr System. The PCr cycling conditions 
consisted of an initial denaturation step at 94 °C for 10 min; 
35 cycles of 94 °C for 1 min, 60 °C for 1 min, 72 °C for 1 
min; and a final extension step at 72 °C for 5 min. Then, the 
rFlP method was used for the determination of -2841A>T 
polymorphism in GLUT1 gene. For this purpose, 337 bp PCr 
products were digested with HpyCH4V restriction enzyme 
(New england Biolabs, Hertfordshire, uK) and incubated 
at 37 0C overnight. digested and undigested products were 
separated by gel electrophoresis on a 2% agarose gel and 
visualized by ethidium bromide so the staining under an 
ultraviolet illuminator. Then, the Syngene monitoring System 
was used for scanning and photographing.  The obtained 
fragments represented the presence of a allele (208+129 bp) 
and the t allele (337 bp) (Figure 1). results of rFlP for each 
variant in 30 randomly selected samples were confirmed 
by dNa sequencing method using the Big-dye terminator 
Cycle Sequencing ready reaction kit on an aBı Prism 3100 
Genetic analyzer. The automated dNa sequencing was 
employed to confirm the authenticity of the amplified PCr 
products.
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Figure 1.  a representative agarose gel image of digested and 
undigested PCr products with HpyCH4V: m: 100-bp ladder; 
lanes 1, 5 and 6: at (337, 208, 129 bp); lanes 2 and 7: aa 
(208, 129 bp); lanes 3 and 4: tt (337 bp); lane 8: undigested 
PCr product (337 bp).
Statistical analysis
The statistical data was analyzed using SPSS 16 software. The 
frequencies of GLUT1 alleles and genotypes were obtained 
by direct count and the χ2 test was used for evaluation of 
the Hardy-Weinberg equilibrium. Continuous variables are 
reported as mean±standard deviation (S.d.). Categorical 
variables were compared by the χ2 test. results were 
considered to be statistically significant at p<0.05.
RESULTS 
The mean age of study subjects was 29.24±4.98 years 
(range 18-41 years). The genotype frequencies were 55.2% 
homozygote typical (AA), 38.1% heterozygote (AT) and 6.7% 
homozygote atypical (TT) (table 1 and 2). The A and T allele 
frequencies were found as 74.3% and 25.7%, respectively. 
The genotype frequencies in all subjects were consistent with 
Hardy-Weinberg equilibrium (χ2 =0.002; p=0.97). 
GLUT1 -2841A>T single nucleotide polymorphism was also 
statistically evaluated for significance with gender and age. 
No significant differences were found between genders and 
ages (p>0.05)
Table 1. distribution of Glut1 -2841a>t  polymorphism in healthy turkish population.
Sample
Genotype frequency Allele frequency
n
(210)
AA AT TT n
(420)
A T
n             % n             % n            % n           % n        %
Female
Male
110
100
57
59
51.8
59.0
44
36
40
36.0
9
5
8.2
5.0
220
200
158
154
71.8
77.0
62
46
28.2
23.0
p 0.471 0.226
Table 2. Comparison of the genotype frequency distributions of Glut1 -2841a>t  polymorphism in turkish population and 
previously published data in other populations.
Population
Genotype frequency
n
AA AT TT
n             % n             % n            %
Turkish (present 
study)
German
British
210
127
99
116
64
32
55.2
50.4
32.3
80
52
65
38.1
40.9
65.7
14
11
2
6.7
8.7
2.0
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DISCUSSION
Single nucleotide polymorphisms are one of the most 
important factors that affect the occurrence of a disease, 
the sensitivity to xenobiotics and/or the side effects of drugs 
between individuals. The development of personalized 
drug therapy, the drug sensitivity and biotransformation 
of drugs is determined by starting with identify SNP (16). 
most SNPs occur in the non-coding region and can be alter 
genes, whereas SNPs occurring in the coding regions could 
alter the protein. a single nucleotide base mutation which 
occurs in the promoter region can affect transcription and 
post-transcription and finally translation although; they 
do not appear in proteins (17). ın present study, -2841A>T 
polymorphism in GLUT1 gene was studied. Because, a 
to t substitution is at – 2841 in the promoter region of 
GLUT1 gene so it can alter the over- or less-expression of 
protein synthesis (8) and there isn’t any study in literature 
about -2841A>T polymorphism in GLUT1 gene in turkish 
population. determination of these polymorphisms is also 
significant information with regard to relation between 
societies. turkey is located in the transition region of europe 
and asia continents. Thus, there is heterogeneity and genetic 
admixture in turkey and the investigation of the allele 
frequencies and genotype distributions of some variants is 
important in a pharmacogenetic interest in this population. 
ın the previous studies the GLUT1 promoter polymorphism 
-2841A>T and its effect to the hepatic carcinoma cells were 
studied in a German population (5). also, the association of 
-2841A>T  polymorphism in GLUT1 promoter region with 
diabetic nephropathy in patients with type 1 diabetes mellitus 
was examined in a British population (8). However, there 
has been no study related to the -2841A>T polymorphism 
in GLUT1 in turkish population. Thus, to the best of our 
knowledge, this is the first research aiming to determine 
the genotype and allele frequencies of GLUT1 -2841A>T 
polymorphism in turkish population. table 2 showed the 
genotype and allele frequencies in turkish, healthy group 
of German and British populations. according to this table, 
distribution of -2841A>T polymorphism in turkish seemed 
to be almost similar with German population, but different 
from British population.
according to the previous studies, the expression of GLUT1 
induces and glucose uptake increases in cancer cells in the 
presence of GLUT1 -2841A>T allele. Thus, required energy 
for anaerobic respiration obtains and proliferation increases. 
Furthermore, in hypoxic condition, due to the anaerobic 
respiration the HıF-1 α binding affinity induces expression 
of GLUT1 (2, 5 and 9). also, there have been some studies 
investigating the relationship of GLUT1 SNPs with the 
development of diabetes. Based on these studies, the a allele 
in -2841 in GLUT1 gene has a protective role against diabetes 
(8). When compare with other genotypes, the glucose uptake 
is less in the presence of a allele. Thus, the pathogenesis of 
hyperglycemia and occurrence of renal disease is slightly less. 
although previous studies indicated that GLUT1 transports 
arsenic as well as glucose in erythrocytes, in blood-brain 
barrier and in epithelial cells (12, 18), the association between 
this GLUT1 and the concentration or transport of arsenic in 
cells has not been studied yet.
our study results may provide a perspective for future 
studies concerning the role of -2841A>T polymorphism in 
GLUT1 gene as a susceptibility factor for cancer and diabetes 
epidemiology. The present results may use as a control group 
for such studies and may assist to develop an individualized 
drug for patients with cancer and diabetes in the future. also, 
further studies need to examine possible correlation between 
the effects of this polymorphism on the accumulation of 
heavy metals in the biological samples.
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Türk popülasyonunda Glukoz Trasnporter 1 geninde 
-2841A>T polimorfizminin allel ve genotip frekansının 
belirlenmesi
ÖZ
Glukoz transporteri (Glut1) hücrenin bazolateralinde 
yer almaktadır ve insulinden bağımsız olarak glukozun 
tek yönlü taşınımını sağlar. Özellikle kanser hücrelerine 
glukoz taşımasından sorumlu olan Glut1 ayrıca, diyabetle 
ilişkili olarak arsenik bileşiklerini de taşınmaktadır. Söz 
konusu çalışma, türk popülasyonundaki Glut1 (a2841t) 
tek nükleotit polimorfizminin allel ve genotip frekansını 
belirlemeyi amaçlamaktadır. Birbirinden bağımsız 100 erkek 
ve 110 kadından kan örnekleri toplanmıştır. Polimeraz Zincir 
reaksiyonu- restriksiyon Fragment uzunluk Polimorfizmi 
tekniği ile kan önrekleri analiz edilmiştir. -2841a>t 
polimorfizminin aa, at ve tt genotiplerine göre dağılımı 
sırasıyla, %55.2, %38.1 ve %6.7’dir. a allelinin sıklığı %74.3, 
t allelinin ise %25.7’dir. istatiksel analizler sonucunda 
elde edilen verilerin, Hardy- Wienberg eşitliği ile uyumlu 
olduğu saptanmıştır. Söz konusu çalışma Glut1 -2841a>t 
polimorfizmini türk popülasyonunda araştıran ilk çalışmadır. 
Sonuç olarak, elde edilen sonuçlar türkiye ve diğer ülkelerdeki 
epidemiyolojik çalışmalarda kullanılabilecektir. 
Anahtar kelimeler: Glukoz transporter 1, türk popülasyonu, 
polimorfizm, HpyCH4
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